US FDA's Cyber Rules: Pure Global on Life Beyond the SBOM

The U.S. FDA has just released transformative new guidance on medical device cybersecurity, moving it from a final-stage checklist to a core requirement throughout the entire product lifecycle. This shift demands a radical new approach, integrating a Secure Product Development Framework (SPDF) from the earliest design stages and extending into post-market surveillance. This change introduces significant new hurdles for MedTech innovators. Consider a scale-up company with a groundbreaking remote monitoring device that was weeks away from FDA submission. Their entire project plan is now on hold. Their existing documentation is insufficient, they lack a formal SPDF, and their investors are growing concerned about the unexpected delays and costs required to meet these stringent new rules, putting their market-entry and financial future at risk. This Episode's Key Questions: - Is your current cybersecurity plan now obsolete under the new FDA guidance? - What exactly is a "Secure Product Development Framework" and how do you build one? - Why is a Software Bill of Materials (SBOM) just the starting point for compliance? - How will these new rules affect your product development timelines and budgets? - What are the new post-market surveillance requirements for cybersecurity? - Can your existing R&D team handle this increased regulatory burden? - How do you prove your device is secure throughout its entire lifecycle? Contact us at [email protected] or visit https://pureglobal.com/ or visit https://pureglobal.ai/ for FREE AI tools and free medical device database.